Stocks in play: Stantec
Will release its fourth-quarter and full-year 2022 financial results after markets close on Wednesday, February 22, 2023. On Thursday, February 23 at 7:00 AM Mountain Time (9:00 AM Eastern Time), Gord Johnston, President and Chief Executive Officer, and Theresa Jang, Executive Vice President and Chief Financial Officer, will hold a webcast and conference call to discuss the Company’s performance. Stantec shares T.STN are trading up $0.22 at $68.99.
Read:
Addressing the USA’s 200 to 1 Security Protection Gap is a Serious Concern for Tech Companies
Latest Set of FDA Fast Track Designations Causing Optimism in Biotech Sector
Biotech Sector to Unveil New Data and Developments at 2022 SABCS in San Antonio
Biotech Sector Witnessing Growing Revenue Potential in Ongoing Battle Against Pancreatic Cancer
New Biotech Sector Drug Combinations Target a Drop in Pancreatic Cancer Mortality Rates